Category: Johnson Johnson

J&J Must Pay $18.8 Million to California Cancer Patient in Baby Powder Suit

Johnson & Johnson’s must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in U.S. bankruptcy court. The jury ruled in favor of…


J&J Sues Biden Administration to Block Medicare Drug Price Negotiations

Johnson & Johnson sued to stop the U.S. government from empowering Health and Human Services (HHS) to negotiate lower drug prices for Medicare recipients. The major drugmaker became the third player in the industry attempting to halt the Medicare drug-price negotiations established by the Inflation Reduction Act (IRA), in a claim filed in the U.S. District…


Johnson & Johnson’s $8.9 Billion Talc Settlement Faces US Bankruptcy Test

Johnson & Johnson’s proposed $8.9 billion settlement of thousands of lawsuits alleging that its talc products cause cancer faces a crucial hurdle this week as a U.S. bankruptcy judge in New Jersey considers whether or not a J&J subsidiary may resolve them by filing for bankruptcy a second time. J&J subsidiary LTL Management’s first attempt…


FDA Revokes Authorization for COVID-19 Vaccine

Just three different COVID-19 vaccines are available in the United States after the U.S. Food and Drug Administration (FDA) on June 1 revoked the authorization for the Johnson & Johnson shot. Regulators made the move because of a request from Janssen, a Johnson & Johnson’s subsidiary that makes the vaccine. Janssen “has informed the FDA…


Johnson & Johnson COVID-19 Vaccine Becomes Unavailable in US

One of the four COVID-19 vaccines authorized in the United States is no longer available, the nation’s public health agency says. The Johnson & Johnson COVID-19 vaccine “is no longer available in the U.S.,” the U.S. Centers for Disease Control and Prevention (CDC) said in a recent update. That’s due to the vaccine expiring on…


Texas Attorney General Investigating Whether COVID-19 Vaccine Manufacturers Misled Public

The highest-ranking prosecutor in Texas is launching an investigation into whether the three top COVID-19 vaccine manufacturers have misled the public. Texas Attorney General Ken Paxton is probing whether Moderna, Pfizer, and Johnson & Johnson misrepresented the efficacy of their COVID-19 vaccines, the Republican announced on May 1. The companies may have violated the Texas Deceptive…


Texas Attorney General to Investigate Whether COVID-19 Vaccine Makers Misled Public

The highest-ranking prosecutor in Texas is launching an investigation into whether the three top COVID-19 vaccine manufacturers have misled the public. Texas Attorney General Ken Paxton is probing whether Moderna, Pfizer, and Johnson & Johnson misrepresented the efficacy of their COVID-19 vaccines, the Republican announced on May 1. The companies may have violated the Texas Deceptive…


Guillain-Barré Syndrome Linked to COVID-19 Vaccine: CDC Study

A disruptive syndrome may be caused by one of the COVID-19 vaccines available in the United States, U.S. officials said in a new study. Seventy-three cases of Guillain-Barré Syndrome, which causes the immune system to attack parts of the nervous system, were confirmed in adults within 42 days of vaccination with Johnson & Johnson’s shot, the U.S. Centers…


Court Rejects Johnson & Johnson Bankruptcy Strategy for Tens of Thousands of Baby Powder Lawsuits

A U.S. court on Monday rejected pharmaceutical company Johnson & Johnson’s bankruptcy strategy to resolve billions of dollars in lawsuits that alleged the firm’s talc products cause cancer. A decision handed down by the U.S. Third Circuit Court of Appeals in Philadelphia dismissed a Chapter 11 petition filed by a recently created J&J subsidiary LTL…


J&J to Pay $40.5 Million to Settle New Hampshire Opioid Lawsuit

Johnson & Johnson has agreed to pay $40.5 million to settle New Hampshire’s claims over the company’s role in the U.S. opioid epidemic, averting a trial that had been scheduled to begin next week. Thursday’s settlement resolves a lawsuit brought in 2018 against Johnson & Johnson and its Janssen Pharmaceuticals unit. New Hampshire accused them…